Reaction

Neutropenic Infection reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 954 reports · 63 co-occurring drugs

As of the last recalculation, Neutropenic Infection appears in 954 FAERS reports alongside 63 co-occurring drug terms. The strongest observed disproportionality signal is BLEOMYCIN SULFATE (PRR 152.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Bleomycin Sulfate	67	152.1	153.1
Doxorubicin	179	53.7	53.8
Busulfan	36	51.8	52.0
Bendamustine Hcl	34	49.6	49.7
Etoposide	136	46.9	47.0
Filgrastim	73	45.8	45.9
Posaconazole Delayed-Release	22	44.7	44.8
Polatuzumab Vedotin	17	38.7	38.7
Dalteparin Sodium	18	37.8	37.9
Cytarabine	93	37.3	37.4
Docetaxel Anhydrous	100	36.0	36.1
Docetaxel	100	36.0	36.1
Posaconazole	25	34.4	34.5
Obinutuzumab	24	32.6	32.7
Cyclophosphamide Injection, Solution	193	29.6	29.6
Cyclophosphamide	193	29.6	29.6
Cyclophosphamide For Injection	193	29.6	29.6
Piperacillin And Tazobactam	17	29.5	29.5
Mesna Injection	11	29.4	29.4
Mesna	11	28.8	28.9
Ifosfamide	26	27.1	27.1
Anti-Thymocyte Globulin (Rabbit)	9	24.6	24.6
Brentuximab Vedotin	11	23.7	23.7
Ganciclovir Sodium	11	22.9	23.0
Fludarabine Phosphate	39	22.5	22.5
Trastuzumab	65	22.1	22.1
Ganciclovir	10	21.5	21.6
Granisetron Hydrochloride	10	21.1	21.1
Granisetron	10	21.0	21.0
Nystatin Ointment	24	20.5	20.5
Nystatin Cream	24	20.4	20.4
Piperacillin Sodium And Tazobactam Sodium	18	20.4	20.4
Azacitidine	26	19.6	19.6
Nystatin	24	19.6	19.6
Rituximab	157	19.2	19.2
Daptomycin	8	19.1	19.1
Piperacillin Sodium,Tazobactam Sodium	22	18.5	18.5
Doxorubicin Hydrochloride	26	17.8	17.8
Carboplatin	94	17.8	17.8
Gemcitabine Hydrochloride	41	17.6	17.6
Leucovorin Calcium	15	17.4	17.4
Cisplatin	58	17.2	17.2
Goserelin	10	16.4	16.4
Instalax Polyethylene Glycol 3350	9	16.0	16.0
Polyethylene Glycol 400	9	15.6	15.6
Gemcitabine	27	15.4	15.4
Travoprost	6	15.2	15.2
Azacitidine For	12	14.6	14.6
Dexamethasone 1.5 Mg	162	14.3	14.3
Dexamethasone	162	14.1	14.2
Pegfilgrastim	56	13.1	13.1
Bendamustine Hydrochloride	7	12.8	12.8
Oxaliplatin	41	12.6	12.6
Fluorouracil Cream, 0.5%	41	12.2	12.2
Vincristine Sulfate	16	12.1	12.1
Fluorouracil	41	12.0	12.0
Amikacin	9	11.6	11.6
Venetoclax	31	11.3	11.3
Bevacizumab	53	9.8	9.8
Bortezomib	36	9.1	9.1
Blinatumomab	4	8.4	8.4
Bosutinib	3	7.3	7.3
Dasatinib	12	7.1	7.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.